Funder: The Mark Foundation for Cancer Research

Due Dates (Anticipated): September 2026 (Letter of Intent) | January 2027 (Full Application)

Funding Amounts: $3,000,000 total over 3 years per award; typically 2 awards per cycle; indirect costs capped at 10% of direct costs.

Summary: Supports collaborative, multidisciplinary research teams aiming for transformative advances in cancer prevention, diagnosis, and treatment.

Key Information: Teams must include 1 PI and 2–8 co-PIs; institutional and submission limits apply.